Total Valuation
Sanofi has a market cap or net worth of $104.61B. The enterprise value is $104.49B.
Market Cap$104.61B
Enterprise Value$104.49B
Share Statistics
Sanofi has 1,214,098,600 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,214,098,600
Owned by Insiders―
Owned by Institutions<0.01%
Financial Efficiency
Sanofi’s return on equity (ROE) is 0.11 and return on invested capital (ROIC) is 7.70%.
Return on Equity (ROE)0.11
Return on Assets (ROA)0.06
Return on Invested Capital (ROIC)7.70%
Return on Capital Employed (ROCE)0.10
Revenue Per Employee563.67K
Profits Per Employee59.59K
Employee Count82,878
Asset Turnover0.34
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Sanofi is 11.9. Sanofi’s PEG ratio is 0.28.
PE Ratio11.9
PS Ratio2.31
PB Ratio1.41
Price to Fair Value1.41
Price to FCF11.23
Price to Operating Cash Flow7.06
PEG Ratio0.28
Income Statement
In the last 12 months, Sanofi had revenue of 46.72B and earned 7.81B in profits. Earnings per share was 6.40.
Revenue46.72B
Gross Profit33.67B
Operating Income9.60B
Pretax Income6.02B
Net Income7.81B
EBITDA12.48B
Earnings Per Share (EPS)6.40
Cash Flow
In the last 12 months, operating cash flow was 12.84B and capital expenditures -1.76B, giving a free cash flow of 11.08B billion.
Operating Cash Flow12.84B
Free Cash Flow11.08B
Free Cash Flow per Share9.13
Dividends & Yields
Sanofi pays an annual dividend of $4.842, resulting in a dividend yield of 4.57%
Dividend Per Share$4.842
Dividend Yield4.57%
Payout Ratio51.95%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.14
52-Week Price Change-7.39%
50-Day Moving Average86.47
200-Day Moving Average89.47
Relative Strength Index (RSI)48.01
Average Volume (3m)7.42K
Important Dates
Sanofi upcoming earnings date is Jul 30, 2026, Before Open (Confirmed).
Last Earnings DateApr 23, 2026
Next Earnings DateJul 30, 2026
Ex-Dividend Date―
Financial Position
Sanofi as a current ratio of 1.09, with Debt / Equity ratio of 27.50%
Current Ratio1.09
Quick Ratio1.09
Debt to Market Cap0.18
Net Debt to EBITDA1.04
Interest Coverage Ratio25.31
Taxes
In the past 12 months, Sanofi has paid 1.04B in taxes.
Income Tax1.04B
Effective Tax Rate0.17
Enterprise Valuation
Sanofi EV to EBITDA ratio is 9.13, with an EV/FCF ratio of 12.67.
EV to Sales2.44
EV to EBITDA9.13
EV to Free Cash Flow12.67
EV to Operating Cash Flow10.59
Balance Sheet
Sanofi has $7.66B in cash and marketable securities with $21.80B in debt, giving a net cash position of -$14.14B billion.
Cash & Marketable Securities$7.66B
Total Debt$21.80B
Net Cash-$14.14B
Net Cash Per Share-$11.65
Tangible Book Value Per Share$3.40
Margins
Gross margin is 71.62%, with operating margin of 32.67%, and net profit margin of 17.91%.
Gross Margin71.62%
Operating Margin32.67%
Pretax Margin13.80%
Net Profit Margin17.91%
EBITDA Margin28.56%
EBIT Margin15.44%
Analyst Forecast
The average price target for Sanofi is $107.77, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$107.77
Price Target Upside12.10% Upside
Analyst ConsensusModerate Buy
Analyst Count9
Revenue Growth Forecast11.19%
EPS Growth Forecast-0.24%